Skip to content

Clinical trials

Phase 3 Pulmonary Embolism trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Phase 3 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20076
20091
20101
20141
20171
20201
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Bristol-Myers Squibb3
Anthos Therapeutics, Inc.2
Assistance Publique - Hôpitaux de Paris2
Daiichi Sankyo2
Sanofi2
Boston Scientific Corporation1
Prof. Stavros Konstantinides, MD1
University of Zurich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism17
Venous Thrombosis12
Venous Thromboembolism6
Thromboembolism2
Thrombosis2
COVID-191
Gastrointestinal Neoplasms1
Hemorrhage1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.